scholarly journals Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system

2009 ◽  
Vol 24 (9) ◽  
pp. 2866-2871 ◽  
Author(s):  
Jean-Pierre Riveline ◽  
Julie Teynie ◽  
Simohamed Belmouaz ◽  
Sylvia Franc ◽  
Dured Dardari ◽  
...  
Keyword(s):  
Glycaemic Control ◽  
Monitoring System ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Continuous Glucose Monitoring System ◽  
Diabetic Patients ◽  
Chronic Haemodialysis ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic

Peritoneal dialysis – risk factor for glycemic variability assessed by continuous glucose monitoring system

2014 ◽  
Vol 21 (1) ◽  
pp. 47-54 ◽  
Author(s):  
Simona Popa ◽  
Cristina Văduva ◽  
Maria Moţa ◽  
Eugen Moţa
Keyword(s):  
Risk Factor ◽  
Peritoneal Dialysis ◽  
Monitoring System ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Glycemic Variability ◽  
Continuous Glucose Monitoring System ◽  
Diabetic Patients ◽  
Type 2 Diabetic

Abstract Background and Aims. Peritoneal dialysis (PD) is accompanied by a multitude of factors that influence glycemic variability, and HbA1c does not detect dynamic glucose changes. In this study we wanted to assess glycemic variability, using a 72-hour continuous glucose monitoring system (CGMS), in 31 patients stratified according to the presence of type 2 diabetes and PD. Materials and Methods. The study included 31 patients (11 type 2 diabetic PD patients, 9 non diabetic PD patients and 11 type 2 diabetic patients without PD). Glycemic variability was assessed on CGM readings by: Mean Amplitude of Glycemic Excursion (MAGE), Mean of Daily Differences (MODD), Fractal Dimensions (FD), Mean Interstitial Glucose (MIG), Area Under glycemia Curve (AUC), M100, % time with glucose >180/<70 mg/dl. Results. The PD diabetic patients presented AUC, MIG and inter-day glycemic variability (MODD) significantly higher than diabetic patients without PD. In PD patients, the type of dialysis fluid in the nocturnal exchange and peritoneal membrane status did not significantly influence glycemic variability. Conclusions. CGMS is more useful than HbA1c in quantifying the metabolic imbalance of PD patients. PD induces inter-day glycemic variability and poor glycemic control, thus being a potential risk factor for chronic complications progression in diabetic patients.

Comparing postprandial efficacy in type 2 diabetic patients receiving mitiglinide and sitagliptin by using continuous glucose monitoring: a pilot study

2014 ◽  
Vol 15 (17) ◽  
pp. 2479-2485 ◽  
Author(s):  
Kiyotaka Ando ◽  
Rimei Nishimura ◽  
Chiaki Seo ◽  
Daisuke Tsujino ◽  
Masaya Sakamoto ◽  
...  
Keyword(s):  
Pilot Study ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic
Sign in / Sign up

Export Citation Format

Share Document